Cancer is a highly heterogeneous disease, meaning it can vary greatly from one patient to another. Factors such as age, sex, genetic makeup, type of cancer, stage of cancer, and overall health can influence how a patient responds to treatment. Therefore, personalized medicine and dose individualization are becoming increasingly important. Personalized dosing aims to tailor the treatment to achieve the best possible outcome for each individual patient.